L3VLUP
ProSign in

SRRK · AMGN in the 13F filings

Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.

SRRKAMGN
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

Holders over time

Tracked managers listing each stock every quarter, at least, or their combined reported value. A gap is a quarter in which no tracked manager listed it. Click a quarter to compare there.
  • SRRK
  • AMGN
0102030202120222023202420252026
Holders and value by quarter
QuarterSRRKAMGN
Q3 20202 holders, $2.5m16 holders, $16.3bn
Q4 20202 holders, $9.4m19 holders, $14.0bn
Q1 20211 holders, $7.0m16 holders, $14.5bn
Q2 20211 holders, $3.9m23 holders, $13.8bn
Q3 20211 holders, $4.5m24 holders, $11.6bn
Q4 2021none listed holders, n.a.21 holders, $10.4bn
Q1 2022none listed holders, n.a.23 holders, $9.9bn
Q2 20222 holders, $3.9m28 holders, $9.7bn
Q3 20221 holders, $508k21 holders, $7.9bn
Q4 20221 holders, $277k24 holders, $9.3bn
Q1 2023none listed holders, n.a.22 holders, $8.4bn
Q2 20232 holders, $3.8m26 holders, $7.4bn
Q3 20232 holders, $4.1m26 holders, $8.7bn
Q4 20233 holders, $195m24 holders, $8.4bn
Q1 20242 holders, $165m25 holders, $6.7bn
Q2 20241 holders, $5.9m20 holders, $8.0bn
Q3 20241 holders, $5.7m21 holders, $8.8bn
Q4 20248 holders, $1.2bn20 holders, $8.2bn
Q1 20258 holders, $933m25 holders, $12.0bn
Q2 20259 holders, $1.1bn20 holders, $10.2bn
Q3 202511 holders, $1.3bn17 holders, $10.4bn
Q4 202510 holders, $1.5bn19 holders, $18.0bn
Q1 202610 holders, $1.9bn15 holders, $21.4bn
Q2 20269 holders, $2.2bn23 holders, $24.9bn
SRRK

Scholar Rock HLDG Corp

Holders
1
Reported value
$5.9m
Buyers
0
Sellers
1

Breadth -1 among 94 comparable managers.

Pharmaceuticals and biotechnologyBiological productsHealthcare: biopharma and medtech · L3VLUP
AMGN

Amgen Inc

Holders
20
Reported value
$8.0bn
Buyers
11
Sellers
9

Breadth +2 among 94 comparable managers.

Pharmaceuticals and biotechnologyBiological productsHealthcare: biopharma and medtech · L3VLUP

Who holds both, Q2 2024

Among the 20 tracked managers listing any of them. "Only" is about listed positions: a manager may hold the other below its listed range.

Only SRRK (0)

None.

Only AMGN (19)

AllianceBernstein LP, ARK Investment Management LLC, Bridgewater Associates LP, Capital Research Global Investors, Caxton Associates LLP, D. E. Shaw & Co., Dodge & Cox, Farallon Capital Management LLC, Fidelity (FMR LLC), Hudson Bay Capital Management LP, Invesco Ltd, Jane Street Group LLC, Janus Henderson Group Ltd, Man Group PLC, Marshall Wace LLP, Neuberger Berman Group LLC, T. Rowe Price Associates Inc, Two Sigma Advisers LP, Two Sigma Investments LP

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.

Back to the 13F Explorer →